ADAPTIVEMOBILE-SECURITY
12.9.2019 09:09:08 CEST | Business Wire | Press release
Following extensive research, AdaptiveMobile Security, a world leader in cyber-telecoms security, today announced it has uncovered a new and previously undetected vulnerability. This vulnerability is currently being exploited and is being used for targeted surveillance of mobile phone users. The vulnerability and its associated attacks have been named, ‘Simjacker’ as it involves the hijacking of SIM cards and threatens mobile phone users across the globe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190912005038/en/
Simjacker extracts the location information of mobile phone users from vulnerable operators, retrieved using malicious SMS messages. The location information of thousands of devices was obtained over time without the knowledge or consent of the targeted mobile phone users. Based on previous intelligence, it is likely that these attacks originated from a surveillance company which works with governments, to track and monitor individuals; bypassing existing signalling protection.
Cathal Mc Daid, Chief Technology Officer of AdaptiveMobile Security explained, “Simjacker represents a clear danger to the mobile operators and subscribers. This is potentially the most sophisticated attack ever seen over core mobile networks. It’s a major wake-up call that shows hostile actors are investing heavily in increasingly complex and creative ways to undermine network security. This compromises the security and trust of customers, mobile operators and impacts the national security of entire countries.”
While the primary attack detected involved the retrieval of mobile phone locations, Simjacker has been further exploited to perform many other types of attacks against individuals and mobile operators such as fraud, scam calls, information leakage, denial of service and espionage. AdaptiveMobile Security Threat Intelligence analysts observed the hackers vary their attacks, testing many of these further exploits.
In theory, all makes and models of mobile phone are open to attack as the vulnerability is linked to a technology embedded on SIM cards. AdaptiveMobile Security research indicates that the Simjacker vulnerability could extend to over 1 billion mobile phone users globally, potentially impacting countries in North and South America, West Africa, Europe, Middle East and indeed any region of the world where this SIM card technology is in use.
Mc Daid continued, “Simjacker worked so well and was being successfully exploited for years because it took advantage of a combination of complex interfaces and obscure technologies, showing that mobile operators cannot rely on standard established defences. Now that this vulnerability has been revealed, we fully expect the exploit authors and other malicious actors will try to evolve these attacks into other areas”.
AdaptiveMobile Security has been working closely with their customers and the wider industry; including both mobile network operators and SIM card manufacturers to protect mobile phone subscribers. AdaptiveMobile Security are committed to using their global threat intelligence to build defences against these new sophisticated attacks that are circumventing current security measures.
Further details on Simjacker are available on www.simjacker.com and Cathal Mc Daid, Chief Technology Officer of AdaptiveMobile Security will be presenting on Simjacker at the Virus Bulletin Conference, London, 3 October 2019.
---Ends---
About
AdaptiveMobile Security is the world leader in cyber-telecoms security, protecting over 2.1 billion subscribers worldwide. The combination of global insight provided by our security specialists teams, our world-leading Threat Intelligence Unit and our proprietary, telecom-grade Network Protection Platform are trusted by the world’s largest service providers to secure their critical communications infrastructure.
The Company HQ is in Dublin with offices in North America, Europe, South Africa, the Middle East and Asia Pacific.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190912005038/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC3.8.2026 03:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that First Plus Asset Management (FPAM), a multi-asset investment management firm, has selected SS&C to provide cross-border operations support across Asia. SS&C will service First Plus across the full investment lifecycle, delivering a scalable, integrated solution supporting transfer agency, order management and execution and investment accounting. FPAM will utilize SS&C to service its growing cross-border operating model and support around $200 million in assets under management*. “As First Plus has expanded, managing our operations has become increasingly complex,” said Jeb Li, Co-Founder and CEO at First Plus. “SS&C’s global footprint and integrated offerings enable us to easily optimize our workflows, so we can focus on scaling quickly and securely while continuing to deliver risk-adjusted returns and best-in-class client service.” The engagement highlights the breadth and scalability of SS&C’s global service model.
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
